NATCO Pharma Limited (NATCOPHARM.NS) NSE
1,071.45
+0.45(+0.04%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,071.45
+0.45(+0.04%)
Currency In INR
| Market Cap | 144.18B |
| Enterprise Value | 125.22B |
| P/E Ratio | 12.32 |
| PEG Ratio | -0.75 |
| Price/Sales Ratio | 4.21 |
| Price/Book Ratio | 2.22 |
| Enterprise/Revenue | 4.24 |
| Enterprise/EBITDA | 9.54 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.34 |
| Operating Margin | 0.4 |
| Return On Assets | 0.15 |
| Return On Equity | 0.2 |
| Revenue | 44.32B |
| Revenue/Share | 254.78 |
| Gross Profit | 37.05B |
| EBITDA | 21.44B |
| Net Income | 18.85B |
| Diluted EPS | 105.26 |
| Total Cash | 40.77B |
| Total Cash/Share | 227.65 |
| Total Debt | 2.61B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.1 |
| Book Value Per Share | 483.26 |
| 52-Week Change | 26.87 |
| 52-Week High | 1,134.85 |
| 52-Week Low | 775 |
| Moving Average 50 Days | 989.54 |
| Moving Average 200 Days | 900.14 |
| Average Volume | 1.56M |
| Shares Outstanding | 179.11M |
| % Held by Institutions | 0.05 |
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.47 |
| Payout Ratio | 0.02 |
| Last Split Factor | 5:1 |
| Last Split Date | November 26, 2015 |